BRIEF-Amgen to present new data from the Repatha cardiovascular outcomes study

* Amgen to present new data from the Repatha cardiovascular outcomes study at ESC congress 2017 Source text for Eikon: Further company coverage:
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.